These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8382319)

  • 41. Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.
    Blair WS; Semler BL
    J Virol; 1991 Nov; 65(11):6111-23. PubMed ID: 1656088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
    Ansardi DC; Morrow CD
    J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Folding and processing of the capsid protein precursor P1 is kinetically retarded in neutralization site 3B mutants of poliovirus.
    Reynolds C; Birnby D; Chow M
    J Virol; 1992 Mar; 66(3):1641-8. PubMed ID: 1310770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1.
    Leclerc C; Deriaud E; Mimic V; van der Werf S
    J Virol; 1991 Feb; 65(2):711-8. PubMed ID: 1702841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants.
    Calvez V; Pelletier I; Couderc T; Pavio-Guédo N; Blondel B; Colbère-Garapin F
    Virology; 1995 Oct; 212(2):309-22. PubMed ID: 7571400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA.
    Kirkegaard K
    J Virol; 1990 Jan; 64(1):195-206. PubMed ID: 2152812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human rhinovirus mutants resistant to low pH.
    Skern T; Torgersen H; Auer H; Kuechler E; Blaas D
    Virology; 1991 Aug; 183(2):757-63. PubMed ID: 1649506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.
    Jewell JE; Ball LA; Rueckert R
    J Virol; 1990 Mar; 64(3):1388-93. PubMed ID: 2154618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eclipse products of poliovirus after cold-synchronized infection of HeLa cells.
    Everaert L; Vrijsen R; Boeyé A
    Virology; 1989 Jul; 171(1):76-82. PubMed ID: 2545039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic stability of poliovirus insertion mutants with a foreign oligopeptide on the capsid surface.
    Christodoulou C; Pelletier I; Colbère-Garapin F
    Res Virol; 1989; 140(6):501-9. PubMed ID: 2559441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Temperature-sensitive lesions in the capsid proteins of the rotavirus mutants tsF and tsG that affect virion assembly.
    Mansell EA; Ramig RF; Patton JT
    Virology; 1994 Oct; 204(1):69-81. PubMed ID: 8091686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Catalysis of poliovirus VP0 maturation cleavage is not mediated by serine 10 of VP2.
    Harber JJ; Bradley J; Anderson CW; Wimmer E
    J Virol; 1991 Jan; 65(1):326-34. PubMed ID: 1845893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Construction of a chimaeric type 1/type 2 poliovirus by genetic recombination.
    Martin A; Wychowski C; Benichou D; Crainic R; Girard M
    Ann Inst Pasteur Virol; 1988; 139(1):79-88. PubMed ID: 2849960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating.
    Asare E; Mugavero J; Jiang P; Wimmer E; Paul AV
    J Virol; 2016 Jul; 90(14):6174-6186. PubMed ID: 27076638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
    Lee PP; Linial ML
    J Virol; 1994 Oct; 68(10):6644-54. PubMed ID: 7521919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of poliovirus P3 proteins using a recombinant vaccinia virus results in proteolytically active 3CD precursor protein without further processing to 3Cpro and 3Dpol.
    Porter DC; Ansardi DC; Lentz MR; Morrow CD
    Virus Res; 1993 Sep; 29(3):241-54. PubMed ID: 8237109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reovirus polypeptide sigma 3 and N-terminal myristoylation of polypeptide mu 1 are required for site-specific cleavage to mu 1C in transfected cells.
    Tillotson L; Shatkin AJ
    J Virol; 1992 Apr; 66(4):2180-6. PubMed ID: 1548757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures.
    Pelletier I; Duncan G; Colbère-Garapin F
    Virology; 1998 Feb; 241(1):1-13. PubMed ID: 9454712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conditional poliovirus mutants made by random deletion mutagenesis of infectious cDNA.
    Kirkegaard K; Nelsen B
    J Virol; 1990 Jan; 64(1):185-94. PubMed ID: 2152811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Construction and characterization of encapsidated poliovirus replicons that express biologically active murine interleukin-2.
    Basak S; McPherson S; Kang S; Collawn JF; Morrow CD
    J Interferon Cytokine Res; 1998 May; 18(5):305-13. PubMed ID: 9620357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.